These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14630510)

  • 1. Drugs and probes: the symbiotic relationship between pharmaceutical discovery and imaging science.
    Maclean D; Northrop JP; Padgett HC; Walsh JC
    Mol Imaging Biol; 2003; 5(5):304-11. PubMed ID: 14630510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular imaging strategies for drug discovery and development.
    Gross S; Piwnica-Worms D
    Curr Opin Chem Biol; 2006 Aug; 10(4):334-42. PubMed ID: 16822702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of positron emission tomography in anticancer drug development.
    Aboagye EO; Price PM
    Invest New Drugs; 2003 May; 21(2):169-81. PubMed ID: 12889738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing new molecular imaging probes for PET.
    Serdons K; Verbruggen A; Bormans GM
    Methods; 2009 Jun; 48(2):104-11. PubMed ID: 19318126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo mouse imaging and spectroscopy in drug discovery.
    Beckmann N; Kneuer R; Gremlich HU; Karmouty-Quintana H; Blé FX; Müller M
    NMR Biomed; 2007 May; 20(3):154-85. PubMed ID: 17451175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular tracers for the PET and SPECT imaging of disease.
    Pimlott SL; Sutherland A
    Chem Soc Rev; 2011 Jan; 40(1):149-62. PubMed ID: 20818455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development.
    Bergström M; Grahnén A; Långström B
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):357-66. PubMed ID: 12937873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography in CNS drug discovery and drug monitoring.
    Piel M; Vernaleken I; Rösch F
    J Med Chem; 2014 Nov; 57(22):9232-58. PubMed ID: 25144329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerating drug discovery and development through in vivo imaging.
    Eckelman WC
    Nucl Med Biol; 2002 Nov; 29(8):777-82. PubMed ID: 12453585
    [No Abstract]   [Full Text] [Related]  

  • 10. A rational regulatory approach for positron emission tomography imaging probes: from "first in man" to NDA approval and reimbursement.
    Barrio JR; Marcus CS; Hung JC; Keppler JS
    Mol Imaging Biol; 2004; 6(6):361-7. PubMed ID: 15564146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring drug-related receptor occupancy with positron emission tomography.
    Passchier J; Gee A; Willemsen A; Vaalburg W; van Waarde A
    Methods; 2002 Jul; 27(3):278-86. PubMed ID: 12183116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular imaging-based early-phase and exploratory clinical research].
    Watanabe Y
    Yakugaku Zasshi; 2013; 133(2):187-95. PubMed ID: 23370512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biomedical imaging in pharmacology with nuclear medical imaging methodologies: positron emission tomography (PET) and single photon emission computed tomography (SPECT)].
    Saji H; Iida Y
    Nihon Yakurigaku Zasshi; 2003 Mar; 121(3):181-91. PubMed ID: 12673952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small animal PET in preclinical studies: opportunities and challenges.
    Riemann B; Schäfers KP; Schober O; Schäfers M
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):215-21. PubMed ID: 18551093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in microscopy and complementary imaging techniques to assess the fate of drugs ex vivo in respiratory drug delivery: an invited paper.
    Park CW; Rhee YS; Vogt FG; Hayes D; Zwischenberger JB; DeLuca PP; Mansour HM
    Adv Drug Deliv Rev; 2012 Mar; 64(4):344-56. PubMed ID: 21920394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging with copper-64.
    Smith SV
    J Inorg Biochem; 2004 Nov; 98(11):1874-901. PubMed ID: 15522415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular imaging applications in nanomedicine.
    Li KC; Pandit SD; Guccione S; Bednarski MD
    Biomed Microdevices; 2004 Jun; 6(2):113-6. PubMed ID: 15320632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity-based probes: discovering new biology and new drug targets.
    Heal WP; Dang TH; Tate EW
    Chem Soc Rev; 2011 Jan; 40(1):246-57. PubMed ID: 20886146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of PET probes for cancer imaging.
    Huang R; Wang M; Zhu Y; Conti PS; Chen K
    Curr Top Med Chem; 2015; 15(8):795-819. PubMed ID: 25732787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of positron emission tomography within the spectrum of medical imaging.
    Jones T
    Eur J Nucl Med; 1996 Feb; 23(2):207-11. PubMed ID: 8925858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.